Kirkland & Ellis advised Frazier Healthcare Partners on the transaction. Frazier Healthcare Partners, a dedicated healthcare private equity firm, announced the closing of its latest flagship...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised The Carlyle Group on the deal. The Carlyle Group (NASDAQ: CG) announced the final closing of its fifth Japanese buyout fund, Carlyle...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis represented Wind Point Partners in the deal. Wind Point Partners, a leading Chicago-based private equity firm, announced the closing of its latest fund,...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented BridgeBio in the transaction. BridgeBio Pharma (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, executed a...
You must be a Standard 1 Year member to access this content.
